Bristol Myers Squibbpress release(NYSE:BMY): Q4 Non-GAAP EPS of $1.83beats by $0.03.Revenue of $12B (+8.1% Y/Y) in-line.Revenue breakdown:Eliquis of $2.67B vs. $2.41B in 3Q21; Opdivo of $1.99B vs. $...
网页链接Bristol Myers Squibbpress release(NYSE:BMY): Q4 Non-GAAP EPS of $1.83beats by $0.03.Revenue of $12B (+8.1% Y/Y) in-line.Revenue breakdown:Eliquis of $2.67B vs. $2.41B in 3Q21; Opdivo of $1.99B vs. $...
网页链接
精彩评论